Press releases

"Our strong performance in the second quarter reflects the consistent execution of our global teams," said Mike Mahoney, CEO of Boston Scientific.

First guidewire designed specifically for TAVI/R now sized for smaller ventricles

First Patients Enrolled in the FAST Feasibility Study

Chairman Pete Nicholas welcomes James as a business leader with “significant financial knowledge, HR management and organizational planning skills.”

Demonstrates growing clinical acceptance for novel, procedure-based treatment option for severe asthma